Mr David Carcedo

Barcelona (Spain)

Follow

Contributor content

How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations?

Presentation

How consistent are cost-effectiveness estimates of a cardiovascular polypill strategy for the secondary prevention of cardiovascular disease across different cardiovascular risk equations?

ESC 365 is supported by

novartis

Explore sponsored resources